Nandabalan Krishnan Insider Trades

Insider Trading History

Track insider trading activity for Nandabalan Krishnan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BioXcel Therapeutics
BioXcel Therapeutics BTAI
10% owner
Holding Value $78.6k 60,000 shares
Last Trade
Apr 06, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.6M 60,000 shares
$276.48
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
10% owner
Holding Value $385k 294,000 shares
Last Trade
Apr 06, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.6M 60,000 shares
$276.48
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
10% owner
Holding Value $0 0 shares
Last Trade
Apr 06, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.6M 60,000 shares
$276.48
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $1.05k 800 shares
Last Trade
Jan 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.21M 25,889 shares
$355.84
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $464k 354,000 shares
Last Trade
Jan 05, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.21M 25,889 shares
$355.84
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $33.9k 25,889 shares
Last Trade
Jan 05, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.21M 25,889 shares
$355.84
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $498k 379,889 shares
Last Trade
Jan 04, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2M 34,111 shares
$356.48
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $12.9k 9,821 shares
Last Trade
Jan 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.66M 24,290 shares
$356.48
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $44.7k 34,111 shares
Last Trade
Jan 04, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2M 34,111 shares
$356.48
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $42.6k 32,550 shares
Last Trade
Nov 11, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.24M 32,550 shares
$253.28
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $542k 414,000 shares
Last Trade
Nov 11, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.24M 32,550 shares
$253.28
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $0 0 shares
Last Trade
Nov 11, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.24M 32,550 shares
$253.28
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $36k 27,450 shares
Last Trade
Nov 10, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.48M 27,450 shares
$236.00
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $585k 446,550 shares
Last Trade
Nov 10, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.48M 27,450 shares
$236.00
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $11.2M 8,546,750 shares
Last Trade
Jun 25, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$235M 473,250 shares
$497.28
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $105k 80,000 shares
Last Trade
Jul 24, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$77.8M 80,000 shares
$972.16
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $11.8M 9,020,000 shares
Last Trade
Jul 24, 2020 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$156M 160,000 shares
$972.16
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
10% owner
Holding Value $12M 9,180,000 shares
Last Trade
Feb 24, 2020 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$155M 300,000 shares
$515.20
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $19.7k 15,000 shares
Last Trade
Jan 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.26M 15,000 shares
$217.60
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $0 0 shares
Last Trade
Apr 01, 2019 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$153k 1,000 shares
$152.96
$1.31

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up